Adverse outcome pathway from activation of the AhR to breast cancer-related death - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Environment International Année : 2022

Adverse outcome pathway from activation of the AhR to breast cancer-related death

Résumé

Adverse outcome pathways (AOPs) are formalized and structured linear concepts that connect one molecular initiating event (MIE) to an adverse outcome (AO) via different key events (KE) through key event relationships (KER). They are mainly used in ecotoxicology toxicology, and regulatory health issues. AOPs must respond to specific guidelines from the Organization for Economic Cooperation and Development (OECD) to weight the evidence between each KE. Breast cancer is the deadliest cancer in women with a poor prognosis in case of metastatic breast cancer. The role of the environments in the formation of metastasis has been suggested. We hypothesized that activation of the AhR (MIE), a xenobiotic receptor, could lead to breast cancer related death (AO), through different KEs, constituting a new AOP. An artificial intelligence tool (AOP-helpfinder), which screens the available literature, was used to collect all existing scientific abstracts to build a novel AOP, using a list of key words. Four hundred and seven abstracts were found containing at least a word from our MIE list and either one word from our AO or KE list. A manual curation retained 113 pertinent articles, which were also screened using PubTator. From these analyses, an AOP was created linking the activation of the AhR to breast cancer related death through decreased apoptosis, inflammation, endothelial cell migration, angiogenesis, and invasion. These KEs promote an increased tumor growth, angiogenesis and migration which leads to breast cancer metastasis and breast cancer related death. The evidence of the proposed AOP was weighted using the tailored Bradford Hill criteria and the OECD guidelines. The confidence in our AOP was considered strong. An in vitro validation must be carried out, but our review proposes a strong relationship between AhR activation and breast cancer-related death with an innovative use of an artificial intelligence literature search.
Fichier principal
Vignette du fichier
1-s2.0-S0160412022002501-main.pdf (1.62 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03745317 , version 1 (04-08-2022)

Identifiants

Citer

Louise Benoit, Florence Jornod, Elias Zgheib, Celine Tomkiewicz, Meriem Koual, et al.. Adverse outcome pathway from activation of the AhR to breast cancer-related death. Environment International, 2022, 165, pp.107323. ⟨10.1016/j.envint.2022.107323⟩. ⟨hal-03745317⟩
12 Consultations
114 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More